Correlation Between Enanta Pharmaceuticals and Eupraxia Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Enanta Pharmaceuticals and Eupraxia Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enanta Pharmaceuticals and Eupraxia Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enanta Pharmaceuticals and Eupraxia Pharmaceuticals Common, you can compare the effects of market volatilities on Enanta Pharmaceuticals and Eupraxia Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enanta Pharmaceuticals with a short position of Eupraxia Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enanta Pharmaceuticals and Eupraxia Pharmaceuticals.
Diversification Opportunities for Enanta Pharmaceuticals and Eupraxia Pharmaceuticals
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Enanta and Eupraxia is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Enanta Pharmaceuticals and Eupraxia Pharmaceuticals Commo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eupraxia Pharmaceuticals and Enanta Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enanta Pharmaceuticals are associated (or correlated) with Eupraxia Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eupraxia Pharmaceuticals has no effect on the direction of Enanta Pharmaceuticals i.e., Enanta Pharmaceuticals and Eupraxia Pharmaceuticals go up and down completely randomly.
Pair Corralation between Enanta Pharmaceuticals and Eupraxia Pharmaceuticals
Given the investment horizon of 90 days Enanta Pharmaceuticals is expected to generate 7.46 times less return on investment than Eupraxia Pharmaceuticals. But when comparing it to its historical volatility, Enanta Pharmaceuticals is 1.28 times less risky than Eupraxia Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Eupraxia Pharmaceuticals Common is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 295.00 in Eupraxia Pharmaceuticals Common on September 2, 2024 and sell it today you would earn a total of 40.00 from holding Eupraxia Pharmaceuticals Common or generate 13.56% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 67.34% |
| Values | Daily Returns |
Enanta Pharmaceuticals vs. Eupraxia Pharmaceuticals Commo
Performance |
| Timeline |
| Enanta Pharmaceuticals |
| Eupraxia Pharmaceuticals |
Enanta Pharmaceuticals and Eupraxia Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enanta Pharmaceuticals and Eupraxia Pharmaceuticals
The main advantage of trading using opposite Enanta Pharmaceuticals and Eupraxia Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enanta Pharmaceuticals position performs unexpectedly, Eupraxia Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eupraxia Pharmaceuticals will offset losses from the drop in Eupraxia Pharmaceuticals' long position.| Enanta Pharmaceuticals vs. Monte Rosa Therapeutics | Enanta Pharmaceuticals vs. Design Therapeutics | Enanta Pharmaceuticals vs. Werewolf Therapeutics | Enanta Pharmaceuticals vs. Ikena Oncology |
| Eupraxia Pharmaceuticals vs. Dogwood Therapeutics, | Eupraxia Pharmaceuticals vs. Enanta Pharmaceuticals | Eupraxia Pharmaceuticals vs. Enveric Biosciences | Eupraxia Pharmaceuticals vs. ESSA Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |